News

Bioseutica®'s latest news

Introducing the Latest Innovations and Developments in Food and Pharmaceutical Industries

Welcome to our news section, where we bring you the latest and most exciting updates from the food and pharmaceutical industries. Stay informed about groundbreaking research, innovative technologies, and significant advancements shaping the future of these dynamic fields. Our expertly curated articles provide insights into the newest trends, regulatory changes, and scientific discoveries impacting food and pharmaceutical products' production, safety, and effectiveness.

Whether you're an industry professional, a researcher, or simply someone interested in the latest health and wellness trends, our news section is your go-to source for reliable and up-to-date information. Explore in-depth analysis, expert opinions, and comprehensive coverage of key topics, including sustainable practices, biotechnology breakthroughs, and consumer safety. Join us as we navigate the evolving landscape of food and pharmaceuticals, highlighting the efforts and achievements that drive progress and innovation.

Stay ahead of the curve and engage with our content to better understand the factors influencing these vital industries. Our commitment to delivering high-quality articles and news ensures you receive relevant and valuable information tailored to your interests and needs. Welcome to a hub of knowledge and discovery—your gateway to the future of food and pharmaceuticals.

EFSA scientific opinion on Lysozyme from hen’s egg
EFSA opinion on Bioseutica's application for Lysozyme from hens’ eggs

EFSA : Lysozyme does not give rise to safety concerns

The food enzyme lysozyme (peptidoglycanN-acetylmuramoylhydrolase; EC 3.2.1.17) is produced from hens eggs by Bioseutica® B.V.  It is intended to be used in brewing processes, milk processing for cheese product

Read more
Bioseutica® Ovotransferrin
Looking for a lactoferrin substitute? Try Ovotransferrin - with similar molecular properties and thermal stability to bovine and human lactoferrin.

Enhancing Protein Product Quality: Ovotransferrin as a Superior Substitute for Lactoferrin

To improve your protein products' processing quality and biological activities? Try using Ovotransferrin as a lactoferrin substitute.

Read more
Bioseutica® Ovotransferrin
Ovotransferrin Supplementation Improves the Iron Absorption: An In Vitro Gastro‐Intestinal Model

Comparative Analysis of Ovotransferrin and Lactoferrin: Iron Transport and Bioactive Properties in Human Health"

Ovotransferrin, a protein abundant in hen egg white, shares many activities as human/bovine lactoferrin.

Read more
Bioseutica® OVOTRANSFERRIN
Functional properties of ovotransferrin from chicken egg white and its derived peptides: a review

Exploring the Potential of Ovotransferrin: Applications in Food and Pharmaceutical Industries

With emerging trends in the food and pharmaceutical industries, potential applications of egg-derived bioactive compounds were recognized.

Read more
Trypsin VI and SE - EFSA Approval
Trypsin VI and SE - EFSA scientific opinions

EFSA Endorses Safety of Bioseutica® Enzymes: Approval Expected in 2023

Bioseutica® is proud to inform you that the European Food Safety Authority (EFSA) has just issued its scientific opinions on two applications submitted by NEOVA Technologies Inc (a Bioseutica® group company) related to the food e

Read more
Ovotransferrin as a novel drug-targeting molecule for cancer chemotherapy
Ovotransferrin as a novel drug-targeting molecule for cancer chemotherapy

Targeted Anticancer Therapy: Ovotransferrin as a Selective Carrier for Enhanced Drug Delivery to Cancer Cells

Despite the discoveries of new anticancer drugs that work on different intracellular targets, many of these drugs have a considerable drawback as they are nonselective, thus causing adverse s

Read more
SARS-COV-2
Lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19

Restoring iron homeostasis and inhibiting replication of SARS-CoV-2

Coronavirus disease 2019 (COVID-19), caused by SARS coronavirus 2 (SARS-CoV-2), is spreading rapidly with no established effective treatments.

Read more
healiva SA
Bioseutica® co-founds Healiva®

Healiva®: a brand new regenerative medicine startup cofounded by Bioseutica®

We are thrilled to introduce Healiva SA, a cutting-edge startup based in Lugano, Switzerland, co-founded by Bioseutica BV.

Read more
Covid19
Bioseutica statement on the COVID-19 outbreak

Bioseutica's COVID-19 pandemic pledge

Zeewolde, March 28, 2020

The COVID-19 pandemic worries us all. Our employees' and their families' health and welfare are paramount in our minds.

Read more
Successful FDA Inspection
Raising the bar of quality excellence

FDA inspected Bioseutica®'s plant in Zeewolde(NTI)

In October 2019, the Food and Drug Administration (FDA) conducted a thorough inspection of our food production plant located in Zeewolde, Netherlands.

Read more
Health Canada GMP inspection
Health Canada GMP inspection
In August 2018 Neova Technologies Inc. (NTI), a Bioseutica Group company had an inspection by Health Canada and received a compliance rating indicating that the activities inspected met the requirements outlined in the Canadian Food & Drug Act and its associated regulations.
Read more